1
Clinical Trials associated with Umbilical cord-derived mesenchymal stromal cells(University of Louisville)University of Louisville - 18642 / CATO Study, Single or Repeated Intravenous Administration of umbiliCAl Cord Mesenchymal sTrOmal Cells in Ischemic Cardiomyopathy
This is a Phase IIA, randomized, double blind, placebo controlled, multicenter study designed to assess the safety, feasibility, and efficacy of umbilical cord derived mesenchymal stromal cells (UC MSCs), administered intravenously (IV) as a single dose or repeated doses, in patients with ischemic cardiomyopathy (ICM).
100 Clinical Results associated with Umbilical cord-derived mesenchymal stromal cells(University of Louisville)
100 Translational Medicine associated with Umbilical cord-derived mesenchymal stromal cells(University of Louisville)
100 Patents (Medical) associated with Umbilical cord-derived mesenchymal stromal cells(University of Louisville)
100 Deals associated with Umbilical cord-derived mesenchymal stromal cells(University of Louisville)